Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Array BioPharma To Present At The 2017 Piper Jaffray Healthcare Conference

By: PR Newswire Association LLC. - 22 Nov 2017

Back to overview list

BOULDER, Colo., Nov. 22, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the 2017 Piper Jaffray Healthcare Conference. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.

Event:	Piper Jaffray Healthcare Conference
Presenter:	Ron Squarer, Chief Executive Officer
Date:	Wednesday, November 29, 2017
Time:	9:00 a.m. Eastern Time
Webcast:	https://event.webcasts.com/starthere.jsp?ei=1171462&tp_key=889917fd39

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Nine registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics).

CONTACT:	Tricia Haugeto
	Array BioPharma Inc.
	303-386-1193
	thaugeto@arraybiopharma.com

View original content with multimedia:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-2017-piper-jaffray-healthcare-conference-300556111.html

SOURCE Array BioPharma Inc.

Related companies:

Array BioPharma

Back to overview list

to the top ↑